Sweetgreen (SG) stock rated Sell: execution risks, costly supply chain, slowing unit growth, and overextended valuation after ...

For the better part of the past decade, Michael Green has been on a mission. From talking to money managers to making the rounds of hedge fund idea dinners to attending conferences geared to everyone ...

European stocks were hit hard by the outbreak of war in Iran and the Middle East, leaving investors concerned about the region and considering whether it still represents a good investment opportunity ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...